| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| BOOKKEEPING | 1,188 | 0 | 0 | 0 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| 2000 BEG, 1500 END, SHS APPLE INC | 140,792 | 288,795 |
| 100 SHS REGENERON PHARMS INC (80 SOLD) | ||
| 100 SHS REGENERON PHARMS INC | ||
| 720 BEG, 450 END, SHS REGENERON PHARMS | 270,000 | 395,231 |
| 1000 SHS HORIZON THERAPEUTICS | ||
| 400 SHS REGENERON PHARMS INC | 262,162 | 351,316 |
| 2000 SHS WEYERHAEUSER CO | 75,730 | 69,540 |
| 2000 SHS WEYERHAEUSER CO | 76,830 | 69,540 |
| 4000 SHS WEYERHAEUSER CO | 139,918 | 139,080 |
| 24 SHS REGENERON | 15,049 | 21,079 |
| 210 SHS HORIZON THERAPEUTICS | ||
| 89.8955 WEYERHAEUSER CO | 3,519 | 3,126 |
| 5 SHS SALESFORCE IN | 1,001 | 1,316 |
| 1 SH VULCAN MATERIALS | 188 | 227 |
| 50 SHS WELLS FARGO & CO | 2,808 | 2,461 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| CEDERBORG & BRET - GENERAL | 1,700 | 0 | 0 | 0 |
| CEDERBORG & BRET - TAX PREPARATION | 3,524 | 0 | 0 | 0 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| CA ATTY GEN'L FILING FEE | 50 | |||
| INSURANCE | 848 | |||
| LAB SUPPLIES | 119 | 119 | ||
| MOVE LAB EQUIPMENT TO CONTRACT RESEARCH | 7,800 | 7,800 | ||
| OFFICE EXPENSE | 100 | |||
| PAYROLL PROCESSSING SERVICE | 100 | 100 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| PROCEEDS FROM ASSETS SOLD 2022 | 1,841 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| CONSULTING | 29,337 | 0 | 0 | 29,337 |